Skip to main content

Thank you for visiting nature.com. You are using a browser version with limited support for CSS. To obtain the best experience, we recommend you use a more up to date browser (or turn off compatibility mode in Internet Explorer). In the meantime, to ensure continued support, we are displaying the site without styles and JavaScript.

  • Review
  • Published:

AP-1 proteins in the adult brain: facts and fiction about effectors of neuroprotection and neurodegeneration

Abstract

Jun and Fos proteins are induced and activated following most physiological and pathophysiological stimuli in the brain. Only few data allow conclusions about distinct functions of AP-1 proteins in neurodegeneration and neuroregeneration, and these functions mainly refer to c-Jun and its activation by JNKs. Apoptotic functions of activated c-Jun affect hippocampal, nigral and primary cultured neurons following excitotoxic stimulation and destruction of the neuron-target-axis including withdrawal of trophic molecules. The inhibition of JNKs might exert neuroprotection by subsequent omission of c-Jun activation. Besides endogenous neuronal functions, the c-Jun/AP-1 proteins can damage the nervous system by upregulation of harmful programs in non-neuronal cells (e.g. microglia) with release of neurodegenerative molecules. In contrast, the differentiation with neurite extension and maturation of neural cells in vitro indicate physiological and potentially neuroprotective functions of c-Jun and JNKs including sensoring for alterations in the cytoskeleton. This review summarizes the multiple molecular interfunctions which are involved in the shift from the physiological role to degenerative effects of the Jun/JNK-axis such as cell type-specific expression and intracellular localization of scaffold proteins and upstream activators, antagonistic phosphatases, interaction with other kinase systems, or the activation of transcription factors competing for binding to JNK proteins and AP-1 DNA elements.

This is a preview of subscription content, access via your institution

Access options

Buy this article

Prices may be subject to local taxes which are calculated during checkout

Figure 1

Similar content being viewed by others

Abbreviations

AP-1:

activator protein 1 (abbreviation for bothproteins and DNA binding sites)

ASK 1:

apoptosis signal-regulating kinase 1

CEP-1347:

Cephalon compound 1347

IEGs:

immediate-early genes

IR:

immunoreactivity

JIPs:

JNK-interacting proteins

JNKs:

c-Jun N-terminal kinases

JSAP1:

JNK-associated protein 1

MKKs:

MAP kinase kinases

MKPs:

MAP kinase phosphatases

MLKs:

mixed-lineage kinases

P13-K:

phosphatidylinositol-3-kinase

SAPKs:

stress activated protein kinases

tPA:

tissue plasminogen activator

PAI-1:

plasminogen-activatorinhibitor 1.

References

  • Almendral JM, Sommer D, Macdonald-Bravo H, Burckhardt J, Perera J, Bravo R . 1988 Mol. Cell. Biol. 8: 2140–2148

  • Anguelova E, Boularand S, Nowicki JP, Benavides J, Smirnova T . 2000 J. Neurosci. Res. 59: 209–217

  • Arts J, Grimbergen J, Bosma PJ, Rahmsdorf HJ, Kooistra T . 1996 Eur. J. Biochem. 241: 393–402

  • Bakiri L, Lallemand D, Bossy-Wetzel E, Yaniv M . 2000 EMBO J. 19: 2056–2068

  • Beer J, Mielke K, Zipp M, Zimmermann M, Herdegen T . 1998 Brain Res. 794: 255–266

  • Behrens A, Sibilia M, Wagner EF . 1999 Nat. Genet. 21: 326–329

  • Brecht S, Simler S, Vergnes M, Mielke K, Marescaux C, Herdegen T . 1999 Brain Res. Mol. Brain Res. 68: 101–108

  • Boss V, Roback JD, Young AN, Roback LJ, Weisenhorn DM, Medina-Flores R, Wainer BH . 2001 J. Neurosci. 21: 18–26

  • Carboni L, Carletti R, Tacconi S, Corti C, Ferraguti F . 1998 Brain Res. Mol. Brain Res. 60: 57–68

  • Carletti R, Tacconi S, Bettini E, Ferraguti F . 1995 Neuroscience 69: 1103–1110

  • Chen J, Kelz MB, Hope BT, Nakabeppu Y, Nestler EJ . 1997 J. Neurosci. 17: 4933–4941

  • Chihab R, Ferry C, Koziel V, Monin P, Daval JL . 1998 Brain Res. Mol. Brain Res. 63: 105–120

  • Coffer P, Lutticken C, van Puijenbroek A, Klop-de Jonge M, Horn F, Kruijer W . 1995 Oncogene 10: 985–994

  • Coffey ET, Hongisto V, Dickens M, Davis RJ, Courtney MJ . 2000 J. Neurosci. 20: 7602–7613

  • Cruzalegui FH, Hardingham GE, Bading H . 1999 EMBO J. 18: 1335–1344

  • Deng T, Karin M . 1994 Nature 371: 171–175

  • Dickens M, Rogers JS, Cavanagh J, Raitano A, Xia Z, Halpern JR, Greenberg ME, Sawyers CL, Davis RJ . 1997 Science 277: 693–696

  • Edelstein K, Beaule C, D'Abramo R, Amir S . 2000 Brain Res. 870: 54–65

  • Eilers A, Whitfield J, Babij C, Rubin LL, Ham J . 1998 J. Neurosci. 18: 1713–1724

  • Elliott RC, Gall CM . 2000 J. Neurosci. 20: 2142–2149

  • Falvo JV, Uglialoro AM, Brinkman BM, Merika M, Parekh BS, Tsai EY, King HC, Morielli AD, Peralta EG, Maniatis T, Thanos D, Goldfeld AE . 2000 Mol. Cell. Biol. 20: 2239–2247

  • Fernyhough P, Gallagher A, Averill SA, Priestley JV, Hounsom L, Patel J, Tomlinson DR . 1999 Diabetes 48: 881–889

  • Ferrell JE . 2000 Science's STKE 52: 1–3

  • Ferrer I, Planas AM, Pozas E . 1997 Neuroscience 80: 449–458

  • Gass P, Herdegen T, Bravo R, Kiessling M . 1993 Eur. J. Neurosci. 5: 933–943

  • Giasson BI, Bruening W, Durham HD, Mushynski WE . 1999 J. Neurochem. 72: 1081–1087

  • Gingrich MB, Traynelis SF . 2000 Trends Neurosci. 23: 399–407

  • Gonzalez MV, Jimenez B, Berciano MT, Gonzalez-Sancho JM, Caelles C, Lafarga M, Munoz A . 2000 J. Cell. Biol. 150: 1199–1208

  • Grimm R, Schicknick H, Riede I, Gundelfinger ED, Herdegen T, Zuschratter W, Tischmeyer W . 1997 Learn. Mem. 3: 402–413

  • Gupta S, Barrett T, Whitmarsh AJ, Cavanagh J, Sluss HK, Derijard B, Davis RJ . 1996 EMBO J. 15: 2760–2770

  • Ham J, Babij C, Whitfield J, Pfarr CM, Lallemand D, Yaniv M, Rubin LL . 1995 Neuron 14: 927–939

  • Han J, Jiang Y, Li Z, Kravchenko VV, Ulevitch RJ . 1997 Nature 386: 296–299

  • Harada J, Sugimoto M . 1999 Jpn. J. Pharmacol. 79: 369–378

  • Hata R, Maeda K, Hermann D, Mies G, Hossmann KA . 2000 J. Cereb. Blood Flow Metab. 20: 306–315

  • Hayashi T, Sakai K, Sasaki C, Zhang WR, Warita H, Abe K . 2000 Neurosci. Lett. 284: 195–199

  • Herdegen T, Claret FX, Kallunki T, Martin-Villalba A, Winter C, Hunter T, Karin M . 1998 J. Neurosci. 18: 5124–5135

  • Herdegen T, Leah JD . 1998 Brain Res. Brain Res. Rev. 28: 370–490

  • Herdegen T, Skene P, Bahr M . 1997 Trends Neurosci. 20: 227–231

  • Herzog KH, Chen SC, Morgan JI . 1999 J. Neurosci. 19: 4349–4359

  • Hilberg F, Aguzzi A, Howells N, Wagner EF . 1993 Nature 365: 179–181

  • Houle JD, Ye JH . 1999 Neuroscience 94: 929–936

  • Hsieh TF, Simler S, Vergnes M, Gass P, Marescaux C, Wiegand SJ, Zimmermann M, Herdegen T . 1998 Exp. Neurol. 149: 161–174

  • Ichijo H . 1999 Oncogene 18: 6087–6093

  • Ikeuchi T, Shimoke K, Kubo T, Yamada M, Hatanaka H . 1998 Hum. Cell 11: 125–140

  • Ito M, Yoshioka K, Akechi M, Yamashita S, Takamatsu N, Sugiyama K, Hibi M, Nakabeppu Y, Shiba T, Yamamoto KI . 1999 Mol. Cell. Biol. 19: 7539–7548

  • Jones KJ . 1993 Brain Res. Bull. 30: 491–498

  • Kallunki T, Deng T, Hibi M, Karin M . 1996 Cell 87: 929–939

  • Kanamoto T, Mota M, Takeda K, Rubin LL, Miyazono K, Ichijo H, Bazenet CE . 2000 Mol. Cell. Biol. 20: 196–204

  • Kenney AM, Kocsis JD . 1998 J. Neurosci. 18: 1318–1328

  • Keyse SM . 1998 Semin. Cell. Dev. Biol. 9: 143–152

  • Kim IJ, Lee KW, Park BY, Lee JK, Park J, Choi IY, Eom SJ, Chang TS, Kim MJ, Yeom YI, Chang SK, Lee YD, Choi EJ, Han PL . 1999 J. Neurochem. 72: 1335–1343

  • Kirch HC, Flaswinkel S, Rumpf H, Brockmann D, Esche H . 1999 Oncogene 18: 2728–2738

  • Kita Y, Kimura KD, Kobayashi M, Ihara S, Kaibuchi K, Kuroda S, Ui M, Iba H, Konishi H, Kikkawa U, Nagata S, Fukui Y . 1998 J. Cell. Sci. 111: 907–915

  • Kolbus A, Herr I, Schreiber M, Debatin KM, Wagner EF, Angel P . 2000 Mol. Cell. Biol. 20: 575–582

  • Kreutz MR, Bien A, Vorwerk CK, Bockers TM, Seidenbecher CI, Tischmeyer W, Sabel BA . 1999 Brain Res. Mol. Brain Res. 69: 232–241

  • Kuboki Y, Ito M, Takamatsu N, Yamamoto K, Shiba T, Yoshioka K . 2000 J. Biol. Chem. 275: 39815–39818

  • Kurokawa T, Katai N, Shibuki H, Kuroiwa S, Kurimoto Y, Nakayama C, Yoshimura N . 1999 Invest. Ophthalmol. Vis. Sci. 40: 3006–3011

  • Lallemand D, Ham J, Garbay S, Bakiri L, Traincard F, Jeannequin O, Pfarr CM, Yaniv M . 1998 EMBO J. 17: 5615–5626

  • Leah JD, Herdegen T, Bravo R . 1991 Brain Res. 566: 198–207

  • Lee JK, Park J, Lee YD, Lee SH, Han PL . 1999 Brain Res. Mol. Brain Res. 70: 116–124

  • Leppa S, Bohmann D . 1999 Oncogene 18: 6158–6162

  • Leppa S, Saffrich R, Ansorge W, Bohmann D . 1998 EMBO J. 17: 4404–4413

  • Levresse V, Butterfield L, Zentrich E, Heasley LE . 2000 J. Neurosci. Res. 62: 799–808

  • Lipton P . 1999 Physiol. Rev. 79: 1431–1568

  • Liu YF, Dorow D, Marshall J . 2000 J. Biol. Chem. 275: 19035–19040

  • Low W, Smith A, Ashworth A, Collins M . 1999 Oncogene 18: 3737–3741

  • Mao Z, Bonni A, Xia F, Nadal-Vicens M, Greenberg ME . 1999 Science 286: 785–790

  • Marinissen MJ, Chiariello M, Pallante M, Gutkind JS . 1999 Mol. Cell. Biol. 19: 4289–4301

  • Maroney AC, Glicksman MA, Basma AN, Walton KM, Knight Jr. E, Murphy CA, Bartlett BA, Finn JP, Angeles T, Matsuda Y, Neff NT, Dionne CA . 1998 J. Neurosci. 18: 104–111

  • Martin JH, Mohit AA, Miller CA . 1996 Brain Res. Mol. Brain Res. 35: 47–57

  • Martin-Villalba A, Herr I, Jeremias I, Hahne M, Brandt R, Vogel J, Schenkel J, Herdegen T, Debatin KM . 1999 J. Neurosci. 19: 3809–3817

  • Marushige K, Marushige Y . 1999 Anticancer Res. 19: 3865–3871

  • McDonald PH, Chow CW, Miller WE, Laporte SA, Field ME, Lin FT, Davis RJ, Lefkowitz RJ . 2000 Science 290: 1574–1577

  • Meriin AB, Yaglom JA, Gabai VL, Zon L, Ganiatsas S, Mosser DD, Sherman MY . 1999 Mol. Cell. Biol. 19: 2547–2555

  • Mielke K, Brecht S, Dorst A, Herdegen T . 1999 Neuroscience 91: 471–483

  • Mielke K, Damm A, Yang DD, Herdegen T . 2000 Brain Res. Mol. Brain Res. 75: 128–137

  • Mielke K, Herdegen T . 2000 Prog. Neurobiol. 61: 45–60

  • Migheli A, Piva R, Atzori C, Troost D, Schiffer D . 1997 J. Neuropathol. Exp. Neurol. 56: 1314–1322

  • Muda M, Theodosiou A, Rodrigues N, Boschert U, Camps M, Gillieron C, Davies K, Ashworth A, Arkinstall S . 1996 J. Biol. Chem. 271: 27205–27208

  • Mulle C, Sailer A, Perez-Otano I, Dickinson-Anson H, Castillo PE, Bureau I, Maron C, Gage FH, Mann JR, Bettler B, Heinemann SF . 1998 Nature 392: 601–605

  • Musti AM, Treier M, Bohmann D . 1997 Science 275: 400–402

  • Nagata K, Puls A, Futter C, Aspenstrom P, Schaefer E, Nakata T, Hirokawa N, Hall A . 1998 EMBO J. 17: 149–158

  • Nakahara S, Yone K, Sakou T, Wada S, Nagamine T, Niiyama T, Ichijo H . 1999 J. Neuropathol. Exp. Neurol. 58: 442–450

  • Namgung U, Xia Z . 2000 J. Neurosci. 20: 6442–6451

  • Napieralski JA, Raghupathi R, Mclntosh TK . 1999 Brain Res. Mol. Brain Res. 71: 78–86

  • Oo TF, Henchcliffe C, James D, Burke RE . 1999 J. Neurochem. 72: 557–564

  • Oren A, Herschkovitz A, Ben-Dror I, Holdengreber V, Ben-Shaul Y, Seger R, Vardimon L . 1999 Mol. Cell. Biol. 19: 1742–1750

  • Ozawa H, Shioda S, Dohi K, Matsumoto H, Mizushima H, Zhou CJ, Funahashi H, Nakai Y, Nakajo S, Matsumoto K . 1999 Neurosci. Lett. 262: 57–60

  • Paratcha G, de Stein ML, Szapiro G, Lopez M, Bevilaqua L, Cammarota M, de Iraldi AP, Izquierdo I, Medina JH . 2000 Brain Res. Mol. Brain Res. 78: 120–130

  • Pellet JB, Haefliger JA, Staple JK, Widmann C, Welker E, Hirling H, Bonny C, Nicod P, Catsicas S, Waeber G, Riederer BM . 2000 Eur. J. Neurosci. 12: 621–632

  • Pena E, Berciano MT, Fernandez R, Crespo P, Lafarga M . 2000 Exp. Cell. Res. 256: 179–191

  • Pennypacker KR, Eidizadeh S, Kassed CA, O'Callaghan JP, Sanberg PR, Willing AE . 2000 Neurosci. Lett. 289: 1–4

  • Perez O, Ntilde OI, Mandelzys A, Morgan JI . 1998 Brain Res. Mol. Brain Res. 53: 41–52

  • Purkiss RJ, Legg MD, Hunt SP, Davies SW . 1993 Eur. J. Neurosci. 5: 1653–1662

  • Raivich G, Bohatschek M, Kloss CU, Werner A, Jones LL, Kreutzberg GW . 1999 Brain Res. Brain Res. Rev. 30: 77–105

  • Rebollo A, Dumoutier L, Renauld JC, Zaballos A, Ayllon V, Martinez AC . 2000 Mol. Cell. Biol. 20: 3407–3416

  • Reynolds CH, Betts JC, Blackstock WP, Nebreda AR, Anderton BH . 2000 J. Neurochem. 74: 1587–1595

  • Rizzo MT, Leaver AH, Yu WM, Kovacs RJ . 1999 Prostaglandins Leukot. Essent. Fatty Acids 60: 187–198

  • Robinson GA . 1995 Brain Res. Mol. Brain Res. 30: 61–69

  • Sabapathy K, Hu Y, Kallunki T, Schreiber M, David JP, Jochum W, Wagner EF, Karin M . 1999 Curr. Biol. 9: 116–125

  • Sadot E, Jaaro H, Seger R, Ginzburg I . 1998 J. Neurochem. 70: 428–431

  • Salehi M, Barron M, Merry BJ, Goyns MH . 1999 Mech. Ageing Dev. 107: 61–71

  • Saporito MS, Thomas BA, Scott RW . 2000 J. Neurochem. 75: 1200–1208

  • Schauwecker PE . 2000 Brain Res. 884: 116–128

  • Sgambato V, Vanhoutte P, Pages C, Rogard M, Hipskind R, Besson MJ, Caboche J . 1998 J. Neurosci. 18: 214–226

  • Sheng M, Pak DT . 2000 Annu. Rev. Physiol. 62: 755–778

  • Skinner M, Qu S, Moore C, Wisdom R . 1997 Mol. Cell. Biol. 17: 2372–2380

  • Small DL, Monette R, Comas T, Fournier M, Morley P . 1999 Brain Res. 842: 376–383

  • Sommer C, Gass P, Kiessling M . 1995 Brain Pathol. 5: 135–144

  • Standen CL, Brownlees J, Grierson AJ, Kesavapany S, Lau KF, McLoughlin DM, Miller CC . 2001 J. Neurochem. 76: 316–320

  • Steward O, Schauwecker PE, Guth L, Zhang Z, Fujiki M, Inman D, Wrathall J, Kempermann G, Gage FH, Saatman KE, Raghupathi R, Mclntosh T . 1999 Exp. Neurol. 157: 19–42

  • Sugino T, Nozaki K, Takagi Y, Hattori I, Hashimoto N, Moriguchi T, Nishida E . 2000 J. Neurosci. 20: 4506–4514

  • Telfeian AE, Federoff HJ, Leone P, During MJ, Williamson A . 2000 Neurobiol. Dis. 7: 362–374

  • Timsit S, Rivera S, Ouaghi P, Guischard F, Tremblay E, Ben-Ari Y, Khrestchatisky M . 1999 Eur. J. Neurosci. 11: 263–278

  • Tsirka SE, Gualandris A, Amaral DG, Strickland S . 1995 Nature 377: 340–344

  • Tsurumi C, Ishida N, Tamura T, Kakizuka A, Nishida E, Okumura E, Kishimoto T, Inagaki M, Okazaki K, Sagata N et al . 1995 Mol. Cell. Biol. 15: 5682–5687

  • Vaudano E, Campbell G, Hunt SP, Lieberman AR . 1998 Eur. J. Neurosci. 10: 2644–2656

  • Virdee K, Bannister AJ, Hunt SP, Tolkovsky AM . 1997 J. Neurochem. 69: 550–561

  • Wang TH, Wang HS, Ichijo H, Giannakakou P, Foster JS, Fojo T, Wimalasena J . 1998 J. Biol. Chem. 273: 4928–4936

  • Watanabe Y, Johnson RS, Butler LS, Binder DK, Spiegelman BM, Papaioannou VE, McNamara JO . 1996 J. Neurosci. 16: 3827–3836

  • Winter C, Schenkel J, Zimmermann M, Herdegen T . 1998 Brain Res. 801: 198–205

  • Wollnik F, Brysch W, Uhlmann E, Gillardon F, Bravo R, Zimmermann M, Schlingensiepen KH, Herdegen T . 1995 Eur. J. Neurosci. 7: 388–393

  • Xia Z, Dickens M, Raingeaud J, Davis RJ, Greenberg ME . 1995 Science 270: 1326–1331

  • Xu J, Kim GM, Ahmed SH, Yan P, Xu XM, Hsu CY . 2001 J. Neurosci. 21: 92–97

  • Xu X, Raber J, Yang D, Su B, Mucke L . 1997 Proc. Natl. Acad. Sci. USA 94: 12655–12660

  • Yang DD, Conze D, Whitmarsh AJ, Barrett T, Davis RJ, Rincon M, Flavell RA . 1998 Immunity 9: 575–585

  • Yang DD, Kuan CY, Whitmarsh AJ, Rincon M, Zheng TS, Davis RJ, Rakic P, Flavell RA . 1997 Nature 389: 865–870

  • Yasuda J, Whitmarsh AJ, Cavanagh J, Sharma M, Davis RJ . 1999 Mol. Cell. Biol. 19: 7245–7254

  • Yujiri T, Fanger GR, Garrington TP, Schlesinger TK, Gibson S, Johnson GL . 1999 J. Biol. Chem. 274: 12605–12610

  • Zhang Y, Zhou L, Miller CA . 1998 Proc. Natl. Acad. Sci. USA 95: 2586–2591

Download references

Author information

Authors and Affiliations

Authors

Rights and permissions

Reprints and permissions

About this article

Cite this article

Herdegen, T., Waetzig, V. AP-1 proteins in the adult brain: facts and fiction about effectors of neuroprotection and neurodegeneration. Oncogene 20, 2424–2437 (2001). https://doi.org/10.1038/sj.onc.1204387

Download citation

  • Issue Date:

  • DOI: https://doi.org/10.1038/sj.onc.1204387

Keywords

This article is cited by

Search

Quick links